Waggershauser et al. reported that TNF inhibitors and ustekinumab show a protective role in preventing respiratory tract infections among older age (> 49 years) [37], and Lichtenstein et al. also reported that patients who received biologics had a significantly milder course of disease [8]. The gene discussed is TNF; the disease is Respiratory tract infection.